University Hospital Muenster Researcher Describes Recent Advances in Anxiety Disorders (Depression and Anxiety in Heart Transplant Recipients: Prevalence and Impact on Post-Transplant Outcomes): Mental Health Diseases and Conditions – Anxiety Disorders

2023 JUN 05 (NewsRx) -- By a News Reporter-Staff News Editor at Insurance Daily News -- Data detailed on anxiety disorders have been presented. According to news originating from Munster, Germany, by NewsRx editors, the research stated, “Depression and anxiety (DA) are common mental disorders in patients with chronic diseases, but the research regarding their prevalence in heart transplantation (HTx) is still limited. We performed an analysis of the prevalence and prognostic relevance of DA in patients who underwent HTx between 2010 and 2018 in Germany.”

Financial supporters for this research include The Federal Joint Committee, Innovation Committee.

The news journalists obtained a quote from the research from University Hospital Muenster: “Data were obtained from Allgemeine Ortskrankenkasse (AOK), which is the largest public health insurance provider. Overall, 694 patients were identified. More than a third of them were diagnosed with DA before undergoing HTx (n = 260, 37.5%). Patients with DA more often had an ischaemic cardiomyopathy (p < 0.001) and a history of previous myocardial infarction (p = 0.001) or stroke (p = 0.002). The prevalence of hypertension (p < 0.001), diabetes (p = 0.004), dyslipidaemia (p < 0.001) and chronic kidney disease (p = 0.003) was higher amongst transplant recipients with DA. Patients with DA were more likely to suffer an ischaemic stroke (p < 0.001) or haemorrhagic stroke (p = 0.032), or develop septicaemia (p = 0.050) during hospitalisation for HTx. Our analysis found no significant differences between the groups with respect to in-hospital mortality. The female sex and mechanical circulatory support were associated with an inferior prognosis. Pretransplant non-ischaemic cardiomyopathy was related to a favourable outcome.”

According to the news reporters, the research concluded: “DA affect up to a third of the population undergoing HTx, with a greater prevalence in patients with comorbidities. DA are associated with a higher incidence of stroke and septicaemia after HTx.”

For more information on this research see: Depression and Anxiety in Heart Transplant Recipients: Prevalence and Impact on Post-Transplant Outcomes. Journal of Personalized Medicine, 2023,13(5). (Journal of Personalized Medicine - http://www.mdpi.com/journal/jpm). The publisher for Journal of Personalized Medicine is MDPI AG.

A free version of this journal article is available at https://doi.org/10.3390/jpm13050844.

Our news editors report that additional information may be obtained by contacting Emyal Alyaydin, Department of Cardiology I-Coronary and Peripheral Vascular Disease, Heart Failure, University Hospital Muenster, Albert Schweitzer Campus 1, A1, 48149 Muenster, Germany. Additional authors for this research include Juergen Reinhard Sindermann, Jeanette Koppe, Joachim Gerss, Patrik Droge, Thomas Ruhnke, Christian Gunster, Holger Reinecke, Jannik Feld.

ORCID is an identifier for authors and includes bibliographic information. The following is ORCID information for the authors of this research: Emyal Alyaydin (http://orcid.org/0000-0001-5139-604X), Jeanette Koppe (http://orcid.org/0000-0003-3640-2995), Joachim Gerss (http://orcid.org/0000-0003-3489-683X), Patrik Droge (http://orcid.org/0000-0003-0263-3154).

(Our reports deliver fact-based news of research and discoveries from around the world.)